Jennifer Lam - Net Worth and Insider Trading

Jennifer Lam Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer Lam owns 1 companies in total, including Reneo Pharmaceuticals Inc (RPHM) .

Click here to see the complete history of Jennifer Lam’s form 4 insider trades.

Insider Ownership Summary of Jennifer Lam

Ticker	Comapny	Transaction Date	Type of Owner
RPHM	Reneo Pharmaceuticals Inc	2022-03-31	VP of Finance & Administration

Jennifer Lam Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jennifer Lam Ownership Network

Ownership Network List of Jennifer Lam

No Data

Ownership Network Relation of Jennifer Lam

Jennifer Lam Owned Company Details

What does Reneo Pharmaceuticals Inc do?

Who are the key executives at Reneo Pharmaceuticals Inc?

Jennifer Lam is the VP of Finance & Administration of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .

Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary

Over the past 18 months, Jennifer Lam made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 1,199,482 shares made by Braden Michael Leonard , and a net sale of 15,625 shares made by Ashley Hall .

In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,563 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 119,948 shares were bought by its insiders, resulting in a net purchase of 118,386 shares.

Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reneo Pharmaceuticals Inc Insider Transactions

No Available Data

Jennifer Lam Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer Lam. You might contact Jennifer Lam via mailing address: C/o Reneo Pharmaceuticals, Inc., 18575 Jamboree Road, Suite 275-s, Irvine Ca 92612.

Discussions on Jennifer Lam

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.